GSK-3117391

CAS No. 1018673-42-1

GSK-3117391 ( CHR-5154;GSK3117391;CHR5154 )

Catalog No. M10089 CAS No. 1018673-42-1

GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 295 Get Quote
25MG 502 Get Quote
50MG 709 Get Quote
100MG 1008 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK-3117391
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
  • Description
    GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor, has the potential to complement existing therapies in the treatment of chronic inflammatory disorders such as rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical
  • Synonyms
    CHR-5154;GSK3117391;CHR5154
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC
  • Research Area
    Inflammation/Immunology
  • Indication
    Rheumatoid Arthritis

Chemical Information

  • CAS Number
    1018673-42-1
  • Formula Weight
    389.50
  • Molecular Formula
    C21H31N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(OC1CCCC1)[C@H](C2CCCCC2)NCC3=CC=C(CCC(NO)=O)N=C3
  • Chemical Name
    cyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • NSC 3852

    NSC 3852 is a potent inhibitor of histone deacetylase.

  • RGFP966

    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay.

  • HDACi-4b

    A benzamide-type HDAC inhibitor with IC50 of 78 uM for changes of FXN mRNA in affected GM15850 cells.